Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease

Am J Gastroenterol. 2016 May;111(5):748-9. doi: 10.1038/ajg.2016.66.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Inflammatory Bowel Diseases
  • Psoriasis
  • Tumor Necrosis Factor-alpha*
  • Ustekinumab*

Substances

  • Tumor Necrosis Factor-alpha
  • Ustekinumab